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Abstract
Synchrotron based X-ray diffraction experiments can be highly effective in the study of 
mammalian connective tissues and related disease. It has been employed here to observe 
changes in the structure of Extra-Cellular Matrix (ECM), induced in an ex vivo tissue based 
model of the disease process underlying diabetes. Pathological changes to the structure 
and organization of the fibrillar collagens within the ECM, such as the formation of non-
enzymatic crosslinks in diabetes and normal aging, have been shown to play an impor-
tant role in the progression of such maladies. However, without direct, quantified and 
specific knowledge of where in the molecular packing these changes occur, development 
of therapeutic interventions has been impeded. In vivo, the result of non-enzymatic glyco-
sylation i.e. glycation, is the formation of sugar-mediated crosslinks, aka advanced glyca-
tion end-products (AGEs), within the native D-periodic structure of type I collagen. The 
locations for the formation of these crosslinks have, until now, been inferred from indi-
rect or comparatively low resolution data under conditions likely to induce experimental 
artifacts. We present here X-ray diffraction derived data, collected from whole hydrated 
and intact isomorphously derivatized tendons, that indicate the location of both native 
(existing) and AGE crosslinks in situ of D-periodic fibrillar collagen.
Keywords: type I collagen, diabetes, crosslinking, advanced glycation end-products, 
X-ray diffraction
1. Introduction
The extracellular matrix (ECM) is a complex network of biomolecules that provides struc-
tural and functional support to cells. Both within and with the ECM, cells proliferate and 
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
form three-dimensional tissues in multicellular organisms. As such, the ECM is important 
to homeostasis, function and survival in higher vertebrates. Varying composition of the 
ECM per tissue, supports widely different biological functions. For instance, blood ves-
sels, organ systems, bones, tendons, skin and so forth although significantly different in 
material properties and cellular-tissue functions, contain many common ECM elements. 
The collagens (there are nearly 30 different types) account for a major part of nearly all 
vertebrate ECMs. Type I collagen is the most predominant collagen found in animals (and 
also found in some insects and plants). It is the major constituent of tendons, ligaments, 
skin, bone, teeth, body organ frameworks and so forth. While type I collagen is surpassed 
in some specific connective tissues (such as in cartilage), major structural features of type 
I collagen appear to be largely common to the other fibril-forming types [1]. Therefore, the 
research presented here, conducted on type I collagen rich tendons, can be used to extend 
our structural understanding of other fibrillar collagens and tissues with fairly reasonable 
extrapolation. This facility is enhanced by the fact that the structure of type I collagen is 
one of the best-defined structures in the collagen family. The in situ packing structure of 
type I collagen from rat-tail tendons has been determined with an associated and publicly 
accessible molecular model resulting from this work [2] (Figure 1). With this structural 
model and the data resulting from this study, the effects of molecular changes in collagen 
Figure 1. Structural hierarchy of type I collagen. The principal components of collagen fibrils are the triple helices 
(~306 nm) that are primarily composed of peptides with a residue sequence of G-X-Y (where X and Y are commonly 
Proline and Hydroxyproline). The triple helical regions of the monomers are flanked on the N and C termini by non-
helical telopeptides. Neighboring collagen molecules are staggered from one another to form the collagen microfibril. 
This is the three-dimensional structure formed by the 67 nm D-periodic repeat comprising an overlap region (where 
5 monomer molecular segments align) and the gap region (4 monomer molecular segments align). Several important 
ligand binding sites are indicated (colored boxes within collagen molecules) on the monomers which adopt a network of 
potentially related sites in the microfibrillar packing of collagen.
Accelerator Physics - Radiation Safety and Applications150
structure and organization brought about by disease may be understood and thus treat-
ments formulated to address them.
1.1. Type I collagen – molecular packing and stabilization
Type I collagen is the major component of rat-tail tendons, the sample tissue of this study. 
These tendons samples are not single crystals; their supramolecular arrays are very large in 
cellular terms and are insoluble. Therefore, normal (single-crystal) crystallographic methods 
cannot be applied without adaptation. Nor is it necessary to form artificial crystals of col-
lagen as the collagen molecules in situ of their tissues are crystalline. They are arranged in a 
quasi-hexagonal packing scheme radially and D-periodic staggered packing scheme longitu-
dinally that form supramolecular structures [1], the microfibril and fibril. The fundamental 
biological units of this ECM protein in animals are the collagen fibrils, which also are the 
crystalline units that diffract X-rays. These fibrils align nearly parallel to each other within 
tendons (Figure 1). As alluded to above, the ~300 nm long collagen molecules align axially 
to form the 67 nm staggered repeat (with 234 amino acids per molecular segment within this 
67 nm repeat) as observed by electron microscopy and X-ray diffraction. This 67 nm repeat is 
referred to as the D-period where fractions of D provide an axial location originating from the 
N-terminal end of the D-period or referring to how much of the D-period is gap or overlap. 
Within these 67 nm repeats, are the overlap region which is 0.46D and the gap region which 
is 0.54D.
The axial (or longitudinal) arrangement of collagen molecules within a fibril is signifi-
cantly more crystalline than the lateral (or radial) packing discussed above, giving a series 
of well-ordered Bragg X-ray reflections along the meridian of the X-ray fiber diffraction 
pattern [3]. Putting the information from both the lateral and axial X-ray diffraction, Orgel 
et al. [2] reported a full 3D structure and accompanying model that is well-accepted and 
regularly forms the basis of structural-function interpretation from the molecular scale 
upwards.
The hierarchical packing structure explained above is maintained in vivo by means of post-
translational modifications to the collagen fibril and through the attachment of stabilizing 
ligands to both the fibril and fibril-bundle(s) [4, 5]. In this present study, we look at the role 
of chemical crosslinks on the axial packing structure of collagen and the specific placement 
within the D-period of these cross-links using X-ray diffraction methodology.
1.2. X-ray fiber diffraction
The principals of X-ray crystallography have been previously applied to study the structure 
of types I and II collagen and how they are adapted to their functional role [1, 2, 6, 7].
As is well known, X-rays are a form of electromagnetic radiation. Much as when visible light 
is incident on an object, the object scatters these rays. For visible light, the scattered rays can 
then be refocused using a lens and these focused rays form an image. For scattered X-rays 
however although theoretically possible, image focus, is in practice not yet achievable for the 
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study of biological samples on the molecular scale. However, as a matter of almost common 
course at this time, the diffracted (scattered) X-rays can be recorded using X-ray detectors 
such as charge coupled devices (CCDs).
Rat-tail tendons diffract focused X-rays to give rise to a series of well-ordered Bragg reflections 
in alignment with the long axis of the tendon, which can be recorded on CCDs. As mentioned 
earlier, these reflections are a result of the crystalline D-periodic packing of collagen along 
the axis [7, 8]. The amplitudes (the square root of recorded intensity) of the Bragg reflections 
extracted from these images can be used with appropriate scaling, along with the missing 
‘phase’ information to calculate electron density maps, along one crystallographic unit cell [9, 
10]. One such method, is to use the known phase information of another known structure; one 
that is isomorphous to the structure under investigation is particularly advantageous. This 
was the method employed for the analyses presented in this study.
Native phases from the previously determined structure of type I collagen were combined 
with the amplitude information obtained from XRD patterns of isomorphous derivatives of 
rat-tail tendons created by incubating them in sugar solutions to create non-enzymatically 
formed chemical crosslinks (analogous to those formed in diabetes and normal aging) and 
further derivatizing them with microscopy dyes specific to these crosslinks. Appropriate scal-
ing of native and isomorphous derivative data can be used to calculate difference Fourier 
and Patterson maps that may be used to locate those differences induced in the experimental 
tendons (glycated tendons) and those that are native (representative of normal, non-diseased 
state). This is based on the same method that was used to determine the structure of type I 
collagen [1, 2, 7]. The phase information from this structure may then be used in creating dif-
ference Fourier maps that indicate the locations of chemical cross-links to a level of accuracy 
that is similar to the resolution of the data used to obtain the maps.
1.3. Fourier and Patterson maps
The diffraction pattern of an object is equivalent to its own Fourier transform. Hence a reverse 
Fourier transform calculated using the amplitudes of the Bragg reflections obtained from 
the XRD patterns and phases would result in a continuous electron density profile along 
one D-period (the axial crystallographic unit cell) of type I collagen. A “difference Fourier” 
can be calculated by using the subtracted difference between derivative (for instance gly-
cated tendon) and native (unmodified tendon) diffraction amplitudes and the phases for the 
native structure. This difference Fourier provides a map of electron densities added to the 
native structure and thus indicate regions in the D-period where chemical modifications have 
occurred.
In addition, calculating the Patterson and difference Patterson function from glycated, dyed and 
unmodified rat-tail tendons gives data on the distribution and the magnitude of electron dense 
regions along the D-period of collagen. The use of the Patterson function provides an important 
cross-verification of the accuracy of the interpretation based on the difference Fourier map/s. 
The key supporting value of the Patterson function, is that it does not rely on phase informa-
tion and is a ‘pure’ observation of key data. This also makes it much more complex in terms of 
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the structure of the molecule, than the electron density maps reconstructed by Fourier maps. A 
molecule with N atoms will give rise to N(N−1)+1 peaks in a Patterson map. However, with the 
proper amino acid sequence information as we have for type I collagen and some knowledge 
of its structure (we have substantial detailed knowledge of its native structure), the Patterson 
map becomes a powerful instrument of model validation for fibrillar collagen structures based 
on X-ray diffraction data [6, 11].
A method of cross-verification between Difference Fourier and Difference Patterson maps has 
been established previously, by using the observed locations of changes in electron densities 
from the difference Fourier to synthesize a “model” Patterson map of the difference between 
derivative and native (i.e. where the crosslinks occur and have been labeled). This is then com-
pared to the observed difference Patterson derived from the amplitudes of the derivative and 
native diffraction patterns. Since the Patterson map is completely unaffected by assumptions 
about phase information, a difference Patterson of derivative and native data should repre-
sent the standard to which a model Patterson should conform. The model Patterson should be 
similar to that of the (model independent) difference Patterson if the Difference Fourier and 
resulting interpretive model are correct (the interpretive model from the Fourier map being 
used to generate the model Patterson function). This approach was applied to the study of 
glycated tendons presented here.
1.4. Enzymatic crosslinks in type I collagen
Enzymatic crosslinking is the formation of stabilizing covalent linkages between collagen 
monomers in the molecular packing of collagen [12]. The mechanism of crosslinking is effec-
tively one of the final steps in the building of fibrils, thereby functionalizing collagen [13]. 
This happens through a specific set of enzymatic reactions at determined locations. A post-
translational enzymatic oxidative deamination of lysine or hydroxylysine residues by the 
enzyme lysyl oxidase results in the formation of intra and intermolecular crosslinks with 
other lysine or hydroxylysine residues (Figure 2). The activity of this enzyme is highly regu-
lated by steric requirements and by the amino acid sequences upstream and downstream of 
the target [14]. The quantification of these crosslinks has been established using chromatog-
raphy [15].
The locations of these enzymatic crosslinks constrain the possible conformation of the C- 
 telopeptides of the two α1 chains to form sharp hairpin turns at around residues 13 and 14 of 
the 25-residue telopeptides [16]. The formation of intermolecular crosslinks at specific sites is 
a stabilizing mechanism for the supramolecular packing of collagen molecules. Impairments 
of crosslinks, either destabilization or hyper stabilization can lead to pathological conditions 
[17–19].
1.5. Glycation
Glycation, also known as Maillard reaction, is a non-enzymatic reaction between reducing sug-
ars and amino groups in proteins, lipids and nucleic acids. It is a process by which  pathologies 
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associated with diabetes progress. The process of glycation involves the generation of a series 
of intermediates including Schiff bases and Amadori products, and ultimately results in the for-
mation of advanced glycation end-products (AGE). This is a slow process, spread over a span of 
a few weeks, making biochemical species with relatively long half-lives, such as collagen, prime 
targets for these reactions [20]. Glycation is a major complication in diabetic patients and is com-
mon in both afflicted animal models and humans [21]. The availability of high concentrations of 
glucose in the blood stream leads to (as yet to be determined) changes in the packing structure 
of collagen which effects and probably impairs, both the functional and mechanical aspects of 
collagen’s role in the ECM (Figure 3). If considerable changes are made to its mechanical prop-
erties, those alterations may in turn, induce or further aid in the progression of pathological 
conditions. Considering the role of fibrillar collagens in the structure of vasculature, as a sole 
target discussed among several possibilities, the significance of these changes becomes readily 
apparent. AGEs are heterogeneous and complex groups of compounds, strongly implicated in 
the pathobiology of diabetes [21]. The initial chemistry behind the formation of AGEs has been 
known since the early 1900s, although a great deal of important information with regards to the 
contribution of AGEs in disease has been uncovered in the last 30 years, even while the specific 
structural sites effected by these changes were yet to be determined.
The process of glycation is a Maillard reaction that can be divided into three broad stages [22]. The 
first stage of glycation is a result of a nucleophilic attack by the amine group, most commonly 
the ε-amino group (side chain) in amino acids such as lysine, on the carbonyl (─CHO) group of the 
sugar in open chain confirmation to form a Schiff base. This is a reversible step [23]. Both pentoses 
and hexoses can take part in this reaction, although only in open chain conformation which gives 
the otherwise closed carbonyl group access to react with the amines from the protein. This Schiff 
base is then rearranged into a relatively more stable Amadori product [22, 24].
The Amadori product formed in the first stage of the glycation reaction breaks down to give 
rise to several compounds, such as glyoxal, methylglyoxal, and 3-deoxyglucosone and vari-
ous other smaller intermediates [22, 24, 25].
Figure 2. Crosslinks at the C-terminal telopeptide formed as a result of lysyl oxidase activity. A crosslink between lysine 
(residue 17) on the C-telopeptide is shown with a hydroxyproline (residue 87) on one of the α1 chains within the triple 
helical region.
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The final/late stage of glycation is a result of the highly reactive α-dicarbonyls from the inter-
mediate stage, reacting with amine and other groups from basic amino acids. After further 
rearrangement of the chemical structures, a large set of potentially varied and stable AGEs are 
formed which permanently alter the structure of the proteins that participated in the reaction. 
These steps are represented in a flow diagram in Figure 4. For a detailed discussion on the 
chemical reaction and the intermediates, see above referenced works.
The structural nature of AGEs is varied. Some AGEs, such as carboxymethyllysine (CML) and 
carboxymethylarginine (CMA), exhibit no special structural characteristics. Some examples 
of lysine-lysine AGEs include glyoxal-lysine dimer (GOLD), methylglyoxal-lysine dimer 
(MOLD), while pentosidine, glucosepane, DOGDIC, MODIC, GODIC are lysine-arginine 
crosslinks [24]. As already mentioned, the overall kinetics of the non-enzymatic process of 
glycation are rather slow. The availability of reducing sugars, mainly glucose, in open chain 
form is fairly limited in the human body but this becomes a significant issue for some  common 
human conditions. Poor glucose control, such as that seen in diabetic patients, can lead to for-
mation and deposition of AGEs in various tissues [26]. Metabolic products of glucose, such 
as glucose-6-phosphate, tend to be faster glycating agents and to react more quickly with 
Figure 4. A schematic representation of the process of glycation in vivo.
Figure 3. A magnified representation of the microfibrillar arrangement of collagen monomers. Mature enzyme-mediated 
(lysyl oxidase) crosslinks are marked in orange and possible, candidate, sugar-mediated (glycation) crosslinks are 
marked in blue. The colored bands in the collagen monomers show ligand binding sites as depicted in Figure 1.
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proteins than this sugar in its native form [20, 27]. The pathological effects of glycation of col-
lagens has been described in various works cited in Table 1.
1.6. Detection of AGEs
The nature of glycation in collagen has been a point of discussion and scientific inquiry for 
at least 30 years. Historically, some researchers have indicated that the process and the loca-
tion of these crosslinks are more or less random and uncontrolled. However, Wess et al. [28] 
speculated based on their X-ray diffraction studies that a few small peaks in their difference 
Fourier maps along with a major peak at the lysine 434 in the gap region of the α1 chain, 
may originate from glycation, and that the process of glycation may be much more specific 
than it was (at that time) assumed. The ability to find the locations of these changes has fur-
ther been fundamentally confounded by the rather small electron density changes brought 
about by the crosslink products, i.e. the AGEs. This makes their detailed study impractical 
with X-ray diffraction, unless additional X-ray diffraction contrast is provided, i.e. added 
electron density to sites specific to these glycation events. This study addresses that need.
Boronic acid derivatives have been used to bind with AGEs and other chemical moieties 
of this class to reproducibly create fluorescent contrast [29–31] in previous experimental 
work, unrelated to X-ray diffraction. Danslyated boronic acids have been used in deter-
mining the concentration of glycation mediated crosslinks in globular and fibrillar pro-
teins and fats have been developed and commonly adopted [32]. These fluorescent contrast 
agents also happen to have, intrinsic to their nature, some significant electron density. 
Thus, although their structures are too large to be functionally useful for high-resolu-
tion single crystal crystallography, they may be exceedingly useful at lower resolution 
Publication and year Glycation associated pathology
Stitt et al., 2005, 1998 Destabilization of the structure of the vitreous gel within the eye
Albon et al., 1995 Age-related changes in the human lamina cribrosa, and the prevalence of chronic open 
angle glaucoma (COAG)
Dyer et al., 1993 Changes in mechanical properties – stiffer and more brittle collagen
Brownlee, 2000 Altered cell proliferation, motility, gene expression and response to cytokines
Gugliucci and Bendayan, 
1996
Increased activation of cytokine (NF-kB) activity resulting in activation of Matrix 
Metalloproteinases (MMP) and increased collagen digestion
Murillo et al., 2008 Impaired wound healing as a result of altered periodontal cell behavior
Thomas & Lascelles, 1966 Accumulation of collagen in the endoneurial interstitium leading to impaired neuronal 
function
Sternberg et al., 1995 End-stage renal disease from glycation of basement membrane in glomeruli
Avendano et al., 1999 Impaired myocardial function from stiffness in collagen in the ventricles
Table 1. Evidence of collagen and AGE related pathologies.
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(nanometer scale) X-ray diffraction analyses; studies akin to those reported here, where 
they effectively form isomorphous derivatives, beyond the upper resolution limit of the 
data collected. Based on these first principles, we present here a method and preliminary 
results we use to identify the location of AGEs within the fibrillar packing of type I collagen 
in rat-tail tendons.
2. Materials and methods
All X-ray diffraction experiments were conducted in situ on rat-tail tendons (RTT). Rat-tail 
tendons were carefully dissected out from the tails of healthy adult rats aged 3–6 months. 
These animals were euthanized, at the time, for other animal studies and the tails were 
generously donated. The tails were immediately stored at −40°C until the time of dissec-
tion for tendons. After dissection, all tendons were stored at 4°C in 10–50 mM Tris Buffered 
Saline (TBS) (Sigma Aldrich St. Louis MO; Cat no. T5912; 10x stock, diluted as needed). 
0.04% (w/v) sodium azide (NaN3) was added to all storage buffers and sample incubations to prevent microbial contamination.
2.1. Sample setup for glycation
0.2 M solution of glucose was made by slowly mixing the appropriate amount of D-glucose 
(Sigma Aldrich St. Louis MO; Cat no. 158968) and the serially diluting the stock to make the 
desired concentrations. All sugar solutions were made in 10 mM TBS. Tendons were depos-
ited in Falcon tubes containing each of the sugar solutions and incubated in a 37°C water bath 
for 20–40 days.
2.2. Treatment with fluorescent dyes
3-(Dansylamino)phenylboronic acid (DPBA) (Sigma Aldrich (St. Louis MO; Cat No. 30423-) 
is a fluorescent dye that binds to the AGEs [32]. A 30 μM stock of DPBA was made in metha-
nol. A working standard DPBA solution at 3 μM was made by diluting the using Phosphate 
Buffered Solution (PBS), at pH 7.4. Non-glycated and glycated tendons were incubated in the 
working standard solution of DPBA for 20 minutes and then washed in PBS for 2 minutes, 
prior to XRD data collection.
2.3. Small and wide angle X-ray diffraction
RTT diffraction patterns were obtained at Biophysics Collaborative Access Team (BioCAT) 
facility at Argonne National Laboratory, Chicago IL. The Mar 165 CCD detector was used 
to collect all small (1–15 Bragg orders) and wide-angle (3–22 Bragg orders) diffraction pat-
terns. The sample to detector distances for small angle (SAX) and wide angle (WAX) X-ray 
diffraction were from 1.5 to 2.5 m and from 25 to 70 cm, respectively. Beamline optics 
were setup to deliver focused X-ray beams at sizes between 50 and 100 μm in width and 
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height (at an average flux of 1013 photons/s) for SAX studies. KB mirrors were used to 
deliver focused beam at 10–60 μm for WAX and micro-WAX studies at a flux of ~1 × 10−12 
photon/s. The sample mount was positioned so that the sample was held at the focal point 
of the beam. The samples were mounted onto the sample compartment, shown in Figure 5, 
immediately before data collection. The sample compartment was mounted on an XY posi-
tioner to move the sample into the beam path. Multiple patterns from each sample were 
collected and the sample was moved, vertically and/or horizontally to limit radiation dam-
age and improve the quality of data. Each point on the tendons was exposed to no more 
than 1 second to the X-rays. Based on the flux of the available beam, if saturation of pixels 
was observed on the diffraction pattern, additional attenuator foils were deployed. The 
same data collection strategies were used to collect data from control, glycated and iodine 
treated samples.
Amplitudes of each reflection from the diffraction patterns were obtained by azimuth-
ally integrating the data from a sector covering the meridional reflection series (Figure 6). 
Difference Fourier and Patterson analyses was performed using the amplitudes and phases 
from native type I collagen as described previously [6, 11, 33]. After appropriate scaling, the 
data from SAX and WAX measurements were combined to improve the resolution of the 
interpretations.
Figure 5. XRD beamline setup and a standard sample cell for fiber XRD data collection. (A) KB mirrors were used to 
deliver a focused beam at the sample position. The sample compartment was placed on a motorized XY-positioner to 
move the sample at the time of recording data. An evacuated flight tube is used to deliver the diffracted (scattered) X-rays 
to the marCCD detector at the end of the tube. The length of the tube can be varied for SAX and WAX experiments. (B) 
Research grade mica windows (thickness 0.15–0.21 mm) are used to cover the windows on either sides of the chamber to 
minimize data loss from any diffracted ray absorption from the compartment itself. An inner sample frame is used to tie 
the tendon onto and then be placed inside the compartment. A cylindrical slot in the bottom enables the entire rig to be 
mounted onto a goniometer head, which can then be controlled remotely. The buffer at the bottom of the compartment 
allows for hydration of tendon by capillary action.
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3. Results and discussion
X-ray diffraction data were interpreted to determine the location of both native crosslinks 
(those formed normally in non-diseased tissue) and those formed through the process of 
sugar incubation in vitro. As stated before, the latter sugar incubation induced cross-links 
simulate the in vivo process of formation of crosslinks through glycation/normal aging. 
Difference Fourier/electron density maps, to a resolution of ~35 Å (19 meridional orders) 
were calculated from these X-ray data. Interpretation of the D-periodic location of existing 
and newly formed crosslinks was then validated by comparison with difference Patterson 
maps. This verified the correct scaling of derivative to native data, the isomorphous nature 
of the derivative data and finally, the correct interpretation of where these crosslinks are 
from comparison of model Patterson functions based on the locations determined for 
crosslinks [6, 11, 33]. The peaks in difference Patterson maps are a result of addition of 
electron densities to specific regions within the unit cell, one of the hallmarks in process-
ing of isomorphous data [9]. The cross verification of the labeling positions determined 
from difference Fourier maps with the relative periodicity spacing indicated by the differ-
ence Patterson maps provides information on the location (and plausible identity) of these 
crosslinks. This is important, since the Patterson maps derived from the experimental data, 
are unbiased by experimenter assumptions. Therefore, the close match between difference 
Patterson functions calculated from observed data and model Patterson functions calcu-
lated from the structure factors derived from a D-periodic model of crosslink locations, 
provides robust verification of the correct determination of the crosslink locations; all the 
more so, since the model of crosslink location is derived directly from difference Fourier 
maps.
Figure 6. WAX diffraction patterns from non-treated (C), glucose- (G) and treated tendons. Red arrows show orders 
where an increase in the intensity of reflection was observed.
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3.1. Preliminary diffraction experiments with glycation
Data collected from glycated tendons showed minor changes in relative intensities (Figure 6). 
Considering the very small change in electron density brought about by the freshly 
formed, sugar-mediated crosslinks, this is to be expected. The small changes detected in 
intensities, however, indicate that there may be isomorphous changes that can be better 
characterized with increased electron density contrast. Contrast agent that binds (also iso-
morphously) to the reaction products (AGEs) where used to make these crosslinks more 
“visible” to X-rays.
3.2. Use of fluorescent dyes to detect crosslinks
As indicated, the use of fluorescent dyes was mandated to add electron density contrast, via 
isomorphous addition of electron density (contrast) to the crosslinks. Compounds known to 
bind to AGE-derived crosslinks for collagen were selected as potential candidates for mul-
tiple isomorphous replacement (MIR). 3-(Dansylamino) phenylboronic acid (DPBA) has been 
demonstrated to increase fluorescence signal by binding to the reaction product from glyca-
tion of bovine serum albumin (BSA) [32]. This property was used to increase the contrast of 
crosslinks (native and AGEs) in glycated and non-glycated collagen samples to reflect in the 
difference Fourier and Patterson maps.
3.3. Difference electron density analysis
As described earlier, difference Fourier and Patterson analysis was performed using the 
amplitudes of the Bragg reflections extracted from the diffraction patterns of glycated and 
non-glycated (control) tendons after treatment with DPBA. Table 2 shows the matrix of dif-
ference Fourier and Patterson analyses performed.
The addition of electron densities due to glycation can be observed in the comparison between 
the difference Fourier maps displayed in Figure 7. Difference Patterson maps, generated from 
these diffraction amplitudes is show in Figure 8. The series of added densities can then be 
Non-glycated Non-glycated + DPBA Glycated Glycated + DPBA








– Invalid calculation Sugar Crosslinks (with 
contrast)
Glycated – Native Crosslinks
Glycated + DPBA –
Table 2. Table showing difference Fourier and Patterson calculated from observed data. A difference Fourier/Patterson 
is simply put, the difference series calculation (the Fourier or the Patterson) between two data sets of structure functions 
(amplitudes). The red and blue text represent the respective series of the same colors shown in Figure 7.
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used to synthesize a model difference Patterson to compare to that obtained from the experi-
mental data to confirm scaling and the application of the right phase information (Figure 8). 
The specific sites of increased electron densities are better demonstrated in Figure 9.
3.4. Interpretation of sites of glycation
Lysine (K), arginine (R) and hydroxylysine (U) residues are the principal residues for cross-
link (both enzymatic and non-enzymatic) formation. Close proximity of these residues to each 
Figure 7. Difference Fourier map from glycated tendons treated with DPBA (blue) and non-glycated (native) tendons 
treated with DPBA (red) along 1D period represented fractional positions. The increase in electron densities or the 
introduction of new peaks in the glycated series, in comparison to the non-glycated, are a result of AGE crosslinks 
formed from the process of glycation.
Figure 8. Model vs. observed difference Patterson maps. Difference Patterson map between glycated and non-glycated 
tendons with DPBA (solid blue line) along 1D period represented in fractional positions. The peak positions show the 
distances between electron dense regions seen in the difference Fourier map (Figure 7). The similarity model Patterson 
(dashed blue line) confirms that the scaling of derivative amplitudes from the XRD patterns and the application of native 
phases is appropriate, thus validating the sequence and structure specific interpretations.
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other within the three-dimensional structure is also a prerequisite to crosslink formation. Two 
very distant candidate residues are unlikely to be involved in crosslink formation, when com-
pared to closely located residues, which cannot be reliably determined without reference to 
the three-dimensional structure. Candidate sites for glycation are spread out throughout the 
sequence (more specifically, the D-period) of collagen (Figure 9). These sites are of partic-
ular importance for the formation of mature enzymatic crosslinks between the non-helical 
telopeptides.
In the N-terminal telopeptide (0.025D) there are clusters of K and U residues which participate 
in the lysyl oxidase-mediated intermolecular crosslink formations. Furthermore, a series of R 
residues in this locale can be involved in AGE formation and hyperstabilize the enzymatic 
formed crosslinks at the N-terminus. Based on our data, these AGEs could potentially com-
pete for the candidate K and U residues involved in the formation of enzymatic crosslinks, 
thus pathologically changing the nature of these crosslinks. Similarly, our data indicate at the 
C-terminal telopeptide (0.43D), a cluster of R residues participate in AGE crosslinking [16]. 
Candidate K and U crosslinking residues on the C-terminal telopeptide are normally the sites 
for enzymatic-intermolecular crosslinking. Together the N- and the C- terminus enzymatic 
crosslinks are prominently involved in the stabilization of the packing structure of collagen 
into fibrils. A possible site for glycation crosslink, adjacent to the N-terminal telopeptides was 
reported by Sweeney et al. [34].
Glycation-mediated crosslinks and possible sites for the formation of these crosslinks are 
described here. The results reported here now provide us with a context for interpretation 
Lysine Arginine
Figure 9. Candidate sites for glycation and regions of increased electron densities from crosslinking within a collagen 
D-period. A linear arrangement of amino acid sequences is shown with lysines (K) and hydroxylysines (U) marked in 
orange and arginines (R) residues marked in green. These positions are aligned with a 3D surface rendered model of the 
collagen microfibril. The linear and 3D representations are also presented in the context of the difference Fourier map 
(Figure 7) with the sites showing regions of increased electron density. An increase in electron density is observed around 
clusters of candidate residues in both representation, thereby supporting the validity of the results. See the discussion on 
the amino acid residues in each of these regions and their relevance to physiology and possible pathologies.
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of the 3D structure of type I collagen with appropriate AGE-related crosslinks and study 
their effects in physiology and disease. For instance, our data indicate the formation of AGE 
crosslinks near the location of the high affinity integrin and von Willebrand Factor (vWF) 
sites. This may have great significance towards explaining the poor wound healing proper-
ties of diabetic tissues. If these crosslinks obscure these high-affinity cell-binding domains in 
the ECM, the tissue is likely significantly impacted in its ability to respond to both wound 
management and the repair of normal wear and tear. Potentially, these data can be used in 
the design of improved therapies, now that a molecular cause is indicated (see following 
discussion).
Notable changes are indicated by increased electron density of isomorphous derivatives, 
evident in difference Fourier maps, along the D-period (67 nm) of type I collagen fibrils in 
those derivative RTT tissues incubated with high concentrations of glucose. This is indica-
tive of significant structural changes, i.e. crosslinking, and is observed from the experimen-
tal data. That these changes are crosslinks is further supported by the presence of crosslink 
labile amino acid sequences found in the regions of the D-period in which the additional 
electron density is observed, thereby confirming that the process of glycation is site-spe-
cific. The fact that these crosslinks alter the packing structure and functional (as in cell 
interactive for instance) properties of collagen is indicated by the proximity of these clus-
ters of crosslinks to highly significant functional sites and regions in the collagen packing 
structure.
The peak indicating additional crosslinking, that appears at 0.1D confirms the glycation site 
proposed by Sweeney et al. [34], with a crosslink between monomers 3 and 4 of the microfi-
bril. Additionally, our data indicate possible AGE crosslinking between monomers 1, 2 and 4. 
The peak at around 0.22D is observed, for which a cluster of principal sites is responsible. This 
location is of particular importance as it is located around the region where monomer 4 of 
one microfibril interacts with another neighboring collagen. The additional crosslinks around 
this location might hyper-stabilize and/or obscure the resulting interaction. This region is also 








 integrin binding sites (GFOGER) [35]. It is worth 
noting that one of the residues in this recognition site is an arginine, which might directly be 
involved in the AGE crosslink. This may well alter integrin-mediated cell adhesion through 
either direct interference (steric hindrance of integrin binding) or by obstructing/delaying the 
limited proteolytic activity of neighboring collagen molecules needed before integrin binds 
at this site.
The crosslinking electron density peaks at 0.3D, 0.38D and 0.46D surround a cluster of key 
cell interaction sites. For example, these AGEs might be significant with respect to the fibro-
nectin and MMP binding sites. Alterations in this physiological phenomenon can severely 
change the accessibility and deposition of collagen in wound healing. Also within close 
proximity of this crosslink are several RGD sequences, which are principal recognition sites 
for 8 of the 24 integrins and a possible explanation for advanced rate of aging and poor 
wound healing ability in diabetic patients [36]. The peaks indicating crosslinks at 0.38D 
and the 0.46D are in the region of the (GPO)
5
 site, which is a potent site for platelet bind-
ing and the process of clotting [4]. This could constitute part of a plausible explanation for 
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the suppressed blood clotting in diabetic patients. This is also of great importance in the 
development of successful surgical implantation materials, such a heart valves and capil-
laries for anastomoses where the ability of the implant material to support clotting is vital. 
Furthermore, a crosslink at 0.46D (gap-overlap interface) can interfere with the fibrillogen-
esis control sequence (FCS) in this region. This site controls the formation of fibrils by form-
ing mature crosslinks to stabilize the molecular packing of collagen monomers into fibrils 
and fibers. The crosslinks at the gap-overlap interface could also alter the packing in such a 
manner that the MMP interaction site becomes more accessible, thereby leading to increased 
proteolysis. Our data also suggest that the crosslink at 0.46D can also interfere with the 
GMOGER site in this region. This has been identified as an important site for integrin-medi-
ated cell binding.
The 0.55D crosslink sites appears immediately adjacent to the C-terminal telopeptides and 
at the beginning of the gap region. At this location, monomer 2 of one microfibril can form a 
crosslink with neighboring collagen monomers to stabilize the packing structure. The signifi-
cance of 0.55D crosslinks are not obvious until it is considered in the context of the 0.38, 0.46 
and the aforementioned 0.55D clusters of crosslinks. Together, they surround the enzymatic 
cleavage-site of collagenase for fibrillar collagen around 0.44D on monomer 4. If there were 
significant glycation induced crosslinking on either side of the collagenase cleavage site, then 
it is possible that even if the enzyme is able to access its substrates-site, which will not be a 
given, it might have little or no impact on the proteolysis of fibrillar collagen as the microfibril 
and fibril will remain intact due to the pathological crosslinks bridging the enzymatic break in 
the collagen molecule. In other words, extensive AGE crosslinking can be seen in this molecu-
lar model, to prevent or hinder wound healing and removal of damaged collagenous tissue, 
which coincides with clinical observations also [21, 37–39].
The peaks indicating crosslinks at the 0.7–0.77D (and a separate peak at 0.88D) are due to the 
high concentration of principal sites of glycation in these regions. In physiology, this region 
is responsible for the binding of small leucine-rich repeat proteoglycans (sLRRP PGs), which, 
using their long glycosaminoglycan chains (GAG) help in bundling fibrils into stable struc-
tures [5]. The crosslinks formed at these sites could result in inherent detachment of the PGs 
leading to disintegration of fibrils. Similar disintegration of fibrils in type II collagen in human 
articular cartilage, as a result of treatment with the biglycan (PG) antibody has been exhibited 
as a plausible mechanism for rheumatoid arthritis [33]. Similar conclusions can be drawn with 
the disintegration of type I collagen fibrils resulting in disease. This region is also the principal 
recognition site for von Willebrand factor binding and crosslinks here could lead to faulty 
coagulation in diabetics. These crosslinks are a possible explanation to how the process of 
thrombosis is affected in diabetic patients [40]. The 0.95D crosslink forms a link between the 
N-terminal of the neighboring collagen molecule. This region is the principal binding region 
for amyloid precursor protein (APP) and is implicated in the pathology of Alzheimer’s disease.
Although all potentially functionally significant, we draw attention again to the significance 
of the additional glycation induced crosslinking that is indicated to occur at 0.38, 0.46 and 
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0.55D. As these locations surround the collagenase cleavage-site, these crosslinks could be 
implicated to interfere with the normal and healthy removal and repair of damaged col-
lagenous tissues. Crosslinks effect these processes, firstly by limiting the availability of the 
collagen’s cleavage site and interaction region at 0.44D; secondly, by hyperstabilizing the 
packing structure, even after the enzymatic cleavage occurs, thereby defeating the release 
of unhealthy collagen fibrils. The 0.7–0.77D region is a second area indicating significant 
glycation induced crosslinking, which directly interferes with and/or hypostabilizes princi-
pal matrix-matrix association regions (via proteoglycan mediated inter-fibrillar crosslinking 
GAG chains) and notable, the von Willebrand factor interaction site in the fibrillar collagen’s 
gap region.
4. Conclusions
There is a strong correlation between the availability of sites for glycation, namely lysine, 
arginine and hydroxylysine residues, their placement in the microfibrillar arrangement and 
the electron density peaks indicating crosslinking in sugar incubated tendons (Figure 9). The 
regions of increased electron density, as a result of glycation induced crosslinks, directly cor-
respond with candidate amino acid crosslinking sites along the collagen microfibril. This data 
appears to experimentally confirm several previously estimated locations for crosslinking 
[34, 41]. The significance of these data to our understanding of the fundamental structure of 
connective tissues and the effects of AGE induced cross-links are immediately apparent as 
discussed above and as follows.
The structure and packing of type I collagen have been objects of study for many decades, 
with the resolution of packing coming to a better level of understanding. There are vari-
ous structural features that contribute to the final fibrillar packing, resulting in the classic 
67 nm repeating D-period. Crosslinking is one of the most important features to stabilize 
their packing into fibrils and in turn, the organization of these fibrils into fibers and the 
bases of tissues and organogenesis. The three-dimensional structure and its derived model 
for collagen, obtained from high-resolution X-ray diffraction studies [2, 7, 16] accounts for 
enzyme-mediated crosslinks, formed as a result of post-translational modification. However, 
molecular dynamics simulations of the packing of type I collagen predict a 11–19% shrink-
age of the 67 nm D-period – which is not what is observed in nature! Therefore, there are 
additional parameters required for molecular dynamic simulations to resemble the observed 
natural structure. Some of this can be attributed to the formation of AGEs as a result of nor-
mal physiological aging and/or sugar-mediated crosslinking [42]. The data presented here, 
give us insight into the location of these crosslinks including which amino acid residues are 
involved and can be used to refine the packing structure and associated simulations of type 
I collagen. These simulations can be used to study plausible collagen related disease mecha-
nisms, to support experimental and clinical data and aid with the development of appropri-
ate therapeutics.
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